MADISON, Wis. (May 20, 2010) – An extensive search for an integrated clinical research management system came to an end in February when Dana-Farber/Harvard Cancer Center (DF/HCC) selected the OnCore(r) system.

“At some level, we’ve been looking for a product over a decade,” said Jeffrey W. Clark, MD, Medical Director of Clinical Trials Operations at DF/HCC, and one of the people who helped spearhead the search for a new system. Unfortunately, a system that was sophisticated enough to handle the complexity of Dana-Farber/Harvard Cancer Center’s seven-institution consortium did not exist until recently. Read More…